Host-Directed Small Molecules, Peptides, and Anticoagulant/Anti-NET Agents
Commercial sector
Host-Directed Small Molecules, Peptides, and Anticoagulant/Anti-NET Agents
Companies developing small-molecule drugs, therapeutic peptides, aptamers, or anticoagulant/anti-NET agents for sepsis that target host pathways such as inflammasomes, kinases, coagulation, vascular leak, or oxidative stress, including lipid and nanoparticle scavengers.
Companies18
Commercial products33
Technology classes1
Countries8
Patents147
Profiled companies
Products
- Vivacelle BioUnited States2
- Matisse Pharmaceuticals B.V.Netherlands4
- Abionyx PharmaFrance1
- AptahemSweden3
- Arch BiopartnersCanada3
- EndaceaUnited States1
+ 12 more